Acute psychomotor, memory and subjective effects of MDMA and THC co-administration over time in healthy volunteers

Journal of Psychopharmacology

Volumn 25, Issue 4, 2011, Pages 478-489

  Dumont, G J H ^a   Van Hasselt, J G C ^b   De Kam, M ^b   Van Gerven, J M A ^b   Touw, D J ^c   Buitelaar, J K ^a   Verkes, R J ^a,d  

^a RADBOUD UNIVERSITY   (Netherlands)

^b CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

^c Department of Hematology   (Netherlands)

^d Pompe Centre for Forensic Psychiatry   (Netherlands)

Author keywords

cannabis; co administration; MDMA; memory; psychomotor; subjective effects

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DRONABINOL;

ADULT; ARTICLE; BODY EQUILIBRIUM; BRAIN FUNCTION; COGNITION; COGNITIVE DEFECT; DRUG EXPOSURE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; SACCADIC EYE MOVEMENT; SMOOTH PURSUIT EYE MOVEMENT; TASK PERFORMANCE; URINALYSIS; VISUAL ANALOG SCALE; WORKING MEMORY;

ADMINISTRATION, INHALATION; ADULT; CANNABIS; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EUPHORIA; FEMALE; HUMANS; MALE; MEMORY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; PLACEBOS; PSYCHOMOTOR PERFORMANCE; TETRAHYDROCANNABINOL; YOUNG ADULT;

EID: 79952488640     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881110376687     Document Type: Article

References (57)

1. Abrams DI, Vizoso HP, Shade SB, Jay C., Kelly ME and Benowitz NL (2007) Vaporization as a smokeless cannabis delivery system: a pilot study. Clin Pharmacol Ther 82: 572-578. (Pubitemid 47622524)
2. Ameri A. (1999) The effects of cannabinoids on the brain. Prog Neurobiol 58: 315-348. (Pubitemid 29230000)
3. Ammons RB (1951) Effect of distribution of practice on rotary pursuit hits. J Exp Psychol 41: 17-22.
4. Bond AJ, James DC and Lader MH (1974) Physiological and psychological measures in anxious patients. Psychol Med 4: 364-373.
5. Bowdle TA, Radant AD, Cowley DS, Kharasch ED, Strassman RJ and Roy-Byrne PP (1998) Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiology 88: 82-88.
6. Boys A., Marsden J. and Strang J. (2001) Understanding reasons for drug use amongst young people: a functional perspective. Health Educ Res 16: 457-469. (Pubitemid 32769161)
7. Choi YH, Hazekamp A., Peltenburg-Looman AM, Frederich M., Erkelens C., Lefeber AW, et al. (2004) NMR assignments of the major cannabinoids and cannabiflavonoids isolated from flowers of Cannabis sativa. Phytochem Anal 15: 345-354. (Pubitemid 39591953)
8. Colado MI, O'Shea E. and Green AR (2004) Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Psychopharmacology (Berl) 173: 249-263. (Pubitemid 38703798)
9. Curran HV, Brignell C., Fletcher S., Middleton P. and Henry J. (2002) Cognitive and subjective dose-response effects of acute oral delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology (Berl) 164: 61-70. (Pubitemid 35203843)
10. D'Souza DC, Perry E., MacDougall L., Ammerman Y., Cooper T., Wu YT, et al. (2004) The psychotomimetic effects of intravenous delta-9- tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29: 1558-1572. (Pubitemid 38982249)
11. D'Souza DC, Ranganathan M., Braley G., Gueorguieva R., Zimolo Z., Cooper T., et al. (2008) Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology 33: 2505-2516.
12. Dumont GJ, Valkenberg MM, Schoemaker R., Buitelaar JK, van Gerven JM and Verkes RJ (2007) Acute MDMA and ethanol interaction effects on psychomotor performance. Br J Clin Pharmacol 63: 503.
13. Dumont GJ and Verkes RJ (2006) A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers. J Psychopharmacol 20: 176-187.
14. Dumont GJ, Wezenberg E., Valkenberg Mmgj, de Jong CAJ, Buitelaar JK, van Gerven JMA, et al. (2008) Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteers. Psychopharmacology (Berl) 197: 465-474.
15. Dumont GJ, Kramers C., Sweep FC, Touw DJ, van Hasselt JG, de Kam M., et al. (2009) Cannabis co-administration potentiates ecstasy effects on heart rate and temperature in humans. Clin Pharm & Ther 86: 160-166.
16. First MB, Frances AJ, Pincus HA, Vettorello N. and Davis WW (1994) DSM-IV in progress. Changes in substance-related, schizophrenic, and other primarily adult disorders. Hosp Community Psychiatry 45: 18-20.
17. Gijsman HJ, van Gerven JM, Verkes RJ, Schoemaker RC, Pieters MS, Pennings EJ, et al. (2002) Saccadic peak velocity and EEG as end-points for a serotonergic challenge test. Hum Psychopharmacol 17: 83-89. (Pubitemid 34257814)
18. Gouzoulis-Mayfrank E. and Daumann J. (2006) The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview. J Psychopharmacol 20: 188-193.
19. Hart CL, van Gorp WG, Haney M., Foltin RW and Fischman MW (2001) Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology 25: 757-765. (Pubitemid 32995958)
20. Hazekamp A., Choi YH and Verpoorte R. (2004) Quantitative analysis of cannabinoids from Cannabis sativa using 1H-NMR. Chem Pharm Bull (Tokyo) 52: 718-721. (Pubitemid 41685511)
21. Hazekamp A., Ruhaak R., Zuurman L., van Gerven J. and Verpoorte R. (2006) Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol. J Pharm Sci 95: 1308-1317. (Pubitemid 43874444)
22. Heishman SJ, Arasteh K. and Stitzer ML (1997) Comparative effects of alcohol and marijuana on mood, memory, and performance. Pharmacol Biochem Behav 58: 93-101. (Pubitemid 27334358)
23. Hernandez-Lopez C., Farre M., Roset PN, Menoyo E., Pizarro N., Ortuno J., et al. (2002) 3,4-methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics. J Pharmacol Exp Ther 300: 236-244. (Pubitemid 34028533)
24. Ilan AB, Gevins A., Coleman M., ElSohly MA and de Wit H. (2005) Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids. Behav Pharmacol 16: 487-496. (Pubitemid 41404822)
25. Ilan AB, Smith ME and Gevins A. (2004) Effects of marijuana on neurophysiological signals of working and episodic memory. Psychopharmacology (Berl) 176: 214-222. (Pubitemid 39517951)
26. Kuypers KP and Ramaekers JG (2005) Transient memory impairment after acute dose of 75mg 3.4-methylene-dioxymethamphetamine. J Psychopharmacol 19: 633-639. (Pubitemid 41578826)
27. Kuypers KP and Ramaekers JG (2007) Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected. Psychopharmacology (Berl) 189: 557-563. (Pubitemid 44791224)
28. Liechti ME and Vollenweider FX (2000) The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('ecstasy') in healthy volunteers. J Psychopharmacol 14: 269-274.
29. Liechti ME and Vollenweider FX (2001) Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies. Hum Psychopharmacol - Clin Exp 16: 589-598. (Pubitemid 34036939)
30. Meeren HK, Van Luijtelaar EL and Coenen AM (1998) Cortical and thalamic visual evoked potentials during sleep-wake states and spike-wave discharges in the rat. Electroencephalogr Clin Neurophysiol 108: 306-319.
31. Meyer-Lindenberg A., Poline JB, Kohn PD, Holt JL, Egan MF, Weinberger DR and Berman KF (2001) Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am J Psychiatry 158: 1809-1817. (Pubitemid 33054773)
32. Mlinar B. and Corradetti R. (2003) Endogenous 5-HT, released by MDMA through serotonin transporter- and secretory vesicle-dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5-HT1B receptors located on CA1 pyramidal neurons. Eur J Neuroscience 18: 1559-1571. (Pubitemid 37215109)
33. Morrison PD, Zois V., McKeown DA, Lee TD, Holt DW, Powell JF, et al. (2009) The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol Med 39: 1607-1616.
34. Orban de Xivry JJ and Lefevre P. (2007) Saccades and pursuit: two outcomes of a single sensorimotor process. J Physiol 584: 11-23. (Pubitemid 47500537)
35. Parrott AC, Gouzoulis-Meyfrank E., Rodgers J. and Solowij N. (2004) Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects. J Psychopharmacol 18: 572-575. (Pubitemid 39665126)
36. Parrott AC, Milani RM, Gouzoulis-Mayfrank E. and Daumann J. (2007) Cannabis and ecstasy/MDMA (3,4-methylenedioxymethamphetamine). an analysis of their neuropsychobiological interactions in recreational users. J Neural Transm 114: 959-968. (Pubitemid 47106452)
37. Parrott AC (2001) Human psychopharmacology of ecstasy (MDMA). a review of 15 years of empirical research. Hum Psychopharmacol 16: 557-577. (Pubitemid 34040989)
38. Pifl C., Drobny H., Reither H., Hornykiewicz O. and Singer EA (1995) Mechanism of the dopamine-releasing actions of amphetamine and cocaine - plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol Pharmacol 47: 368-373.
39. Ploner CJ, Tschirch A., Ostendorf F., Dick S., Gaymard BM, Rivaud-Pechoux S., et al. (2002) Oculomotor effects of delta-9-tetrahydrocannabinol in humans: implications for the functional neuroanatomy of the brain cannabinoid system. Cereb Cortex 12: 1016-1023.
40. Ramaekers JG, Robbe HW and O'Hanlon JF (2000) Marijuana, alcohol and actual driving performance. Hum Psychopharmacol 15: 551-558.
41. Ranganathan M. and D'Souza DC (2006) The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology (Berl) 188: 425-444. (Pubitemid 44498214)
42. Ronen A., Gershon P., Drobiner H., Rabinovich A., Bar-Hamburger R., Mechoulam R., et al. (2008) Effects of THC on driving performance, physiological state and subjective feelings relative to alcohol. Accid Anal Prev 40: 926-934.
43. Sewell AR, Poling J and Sofuoglu M (2009) The effect of cannabis compared with alcohol on driving. Am J Addictions 18: 185-219.
44. Sprague JE, Brutcher RE, Mills EM, Caden D. and Rusyniak DE (2004) Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-induced rhabdomyolysis with alpha1- plus beta3-adrenoreceptor antagonists. Br J Pharmacol 142: 667-670. (Pubitemid 38969661)
45. Strougo A., Zuurman L., Roy C., Pinquier J., van Gerven J., Cohen A., et al. (2008) Modelling of the concentration-effect relationship of THC on central nervous system parameters and heart rate - insight into its mechanisms of action and a tool for clinical research and development of cannabinoids. J Psychopharmacol 22: 717-726.
46. Sumnall HR, Cole JC and Jerome L. (2006) The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy. J Psychopharmacol 20: 670-682. (Pubitemid 44315867)
47. Sundstrom I. and Backstrom T. (1998) Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial. Psychoneuroendocrinology 23: 73-88. (Pubitemid 28252969)
48. Svrakic DM, Whitehead C., Przybeck TR and Cloninger CR (1993) Differential diagnosis of personality disorders by the seven-factor model of temperament and character. Arch Gen Psychiatry 50: 991-999. (Pubitemid 23361479)
49. Vakil E. and Blachstein H. (1993) Rey auditory-verbal learning test: structure analysis. J Clin Psychol 49: 883-890. (Pubitemid 23361803)
50. van Steveninck AL, van Berckel BN, Schoemaker RC, Breimer DD, van Gerven JM and Cohen AF (1999) The sensitivity of pharmacodynamic tests for the central nervous system effects of drugs on the effects of sleep deprivation. J Psychopharmacol 13: 10-17. (Pubitemid 29141271)
51. Wachtel SR, ElSohly MA, Ross SA, Ambre J, de and Wit H. (2002) Comparison of the subjective effects of delta(9)-tetrahydrocannabinol and marijuana in humans. Psychopharmacology (Berl) 161: 331-339. (Pubitemid 34595783)
52. Weinstein A., Brickner O., Lerman H., Greemland M., Bloch M., Lester H., et al. (2008) Brain imaging study of the acute effects of delta9- tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuana. Psychopharmacology (Berl) 196: 119-131.
53. Winstock AR, Griffiths P. and Stewart D. (2001) Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug Alcohol Depend 64 (1). 9-17. (Pubitemid 32695429)
54. Wright BM (1971) A simple mechanical ataxia-meter. J Physiol 218: 27P - 28P.
55. Young JM, McGregor IS and Mallet PE (2005) Co-administration of THC and MDMA ('ecstasy') synergistically disrupts memory in rats. Neuropsychopharmacology 30: 1475-1482. (Pubitemid 41153119)
56. Zuurman L., Roy C., Schoemaker RC, Hazekamp A., den Hartigh J., Bender JC, et al. (2008) Effect of intrapulmonary tetrahydrocannabinol administration in humans. J Psychopharmacol 22: 707-716.
57. Zuurman L., Ippel AE, Moin E and van Gerven JM (2009) Biomarkers for the effects of cannabis and THC in healthy volunteers. Br J Clin Pharmacol 67: 5-21.